CPDA-1 188 mg/63mL (Anticoagulant Citrate Phosphate Dextrose Adenine SOLUTION) 188 mg/63mL

CPDA-1 188 mg/63mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, designed for blood storage and transfusion purposes.

Strength

188 mg/63mL

Pack Size

63 mL in 1 BAG (0942-9398-02)

Manufacturer / TM Owner

Fenwal, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CPDA-1 188 mg/63mL is primarily used to prevent blood clotting during storage. This anticoagulant solution is commonly employed in medical settings to extend the shelf life of blood components, ensuring they remain viable for transfusion. It is often used in hospitals and blood banks to maintain the quality of stored blood.

Side Effects

The primary effect of CPDA-1 188 mg/63mL is to inhibit clotting, allowing blood to be stored safely. This solution helps preserve the red blood cells and other components, ensuring they remain effective for medical use. Users may notice the solution's clear appearance and its role in maintaining blood integrity.

Precautions & Warnings

CPDA-1 188 mg/63mL should be handled with care to avoid contamination. It is essential to follow proper storage guidelines and use sterile techniques when administering the solution. Always check the solution for any signs of damage or discoloration before use.

Avoid Interactions

CPDA-1 188 mg/63mL may interact with certain medications or substances. It is important to consult healthcare professionals regarding potential interactions, especially with other anticoagulants or blood-thinning agents. Always inform your healthcare provider about any medications you are taking.

Frequently Asked Questions

CPDA-1 188 mg/63mL is used to prevent blood clotting during storage, preserving blood components for transfusion.

CPDA-1 188 mg/63mL should be stored according to the manufacturer's guidelines to maintain its effectiveness.

The primary effect is to inhibit clotting, allowing blood to be stored safely and maintaining the integrity of blood components.

Potential interactions may occur with other anticoagulants or blood-thinning agents; consult a healthcare professional for advice.

CPDA-1 188 mg/63mL is designed for general use in blood preservation, but specific compatibility should be confirmed with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.